You are here
Valeant's new chief cuts a familiar figure
WHEN a deeply troubled company replaces its chief executive, it makes sense to expect the new CEO to bring a fresh take to its operations. A clean sweep, so to speak.
But if shareholders in Valeant Pharmaceuticals International envisage a vastly different approach by
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org